Lovaltech | 🧬 French biotech company specializing in the development of innovative nasal vaccines. Protecting the world, more effectively and more simply. 🛡️
Tours
Joined April 2026
- Tweets36
- Following99
- Followers12
- Likes62
Lovaltech is :
✅ An exclusive global license
💰 €17 million in funding secured
🧬 A technology platform dedicated to nasal vaccination
🧪 A successfully completed Phase I clinical trial
📅 Phase II scheduled for November 2026
🚀 And other projects in progress and coming soon…
#Deeptech #Vaccines #MucosalImmunity
🤖 Made with AI
Vous avez été des centaines à croire en nous sur @tudigoFR. Merci !🙏
La campagne de financement de Lovaltech se clôture avec succès. Votre soutien est le moteur de notre innovation. Nous avons hâte de vous partager la suite de nos avancées.✨
#Crowdfunding #Innovation #Merci
🤖 Made with AI
🧬 Phase I validated | €17M raised | Phase II underway (results by late 2027).
A 100% French breakthrough technology, proudly developed in the laboratories of the University of Tours and @INRAE_France. 🇫🇷🌱
#Deeptech #Vaccines #MucosalImmunity
🏁 Dernière ligne droite pour Lovaltech ! Objectifs dépassés avec +500 investisseurs mobilisés pour réinventer la vaccination par voie intranasale. Un immense merci. 🧬🔥
Pourquoi nous rejoindre avant la clôture ?
Pour nous donner les moyens de :
🧪 Valider notre Phase II clinique
💻 Accélérer notre plateforme R&D
🩺 Faire avancer le programme #COVIDLong
🤝 Négocier nos partenariats et licences avec la pharma
Notre mission : cibler les muqueuses pour réduire drastiquement la transmission des agents infectieux.
Deadline pour investir ici ➡️ tdgo.co/5zo3lt
#Innovation #Investissement #France2030
L’#Hantavirus est au cœur de l’actualité. Notre plateforme pourrait-elle servir de base pour un vaccin nasal ? 🤔
Si nos priorités restent le #COVIDLong, la grippe et la préparation pandémique, nos technologies sont prêtes à pivoter en cas d'urgence. 🧪
A great preparation for a stronger future for Lovaltech!
A big thank you to Euronext for the quality of their support throughout this demanding and inspiring journey. 👍
#IPOready #Euronext #StockMarket #Biotech
Why do we talk about global health (#OneHealth)?
🦠+🌱+👤
Because 75% of emerging human diseases originate in animals. Anticipating tomorrow’s needs requires looking at the living world as a whole.
This is Lovaltech’s scientific compass. 🚀
#Biotech #Prevention #EcoHealth
The key to preventing transmission lies not in reacting, but in anticipating. 🌍
Unraveling the complexities of viral spread is at the heart of our mission.
Our teams tackle this technological challenge every day to develop more effective and sustainable protection. ✨
#Biotech #FutureOfHealth #Deeptech
🤖 Made with AI
Proud to embody local innovation! 🚀
On May 6th, the President of @lovaltech attended a private dinner with H.S.H. Prince Albert II of Monaco and the Prefect of Indre-et-Loire.
It was a key opportunity to showcase our major breakthrough : a nasal vaccine that blocks the transmission of viruses. 🧬🛡️
🔜Next step: Monaco in September for a presentation to the local economic circle.
#DeepTech #PrinceOfMonaco #Immunology
Together with our partners, we are developing a strategy based on mucosal immunity to address the root causes of persistent symptoms.
Acting today for tomorrow’s health. ✨
#Innovation #HealthTech #LongCovid
🔍 Science Spotlight: Do you know about IgA?
While traditional antibodies circulate in the blood, IgA antibodies are the true “guardians” of our mucous membranes—especially those in the nose. 🛡️
By stimulating their production right at the virus’s point of entry, Lovaltech aims to block transmission from the very first contact. No entry, no infection! 🚫🦠
#Lovaltech #Immunology #IgA #Innovation #Health
🤖 Made with AI
